NCT05683093Recruiting
Cardiovascular Longitudinal ALSPAC Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Cardiovascular Longitudinal the Avon Longitudinal Study of Parents and Children (ALSPAC) Research Investigations Following Hypertensive Pregnancy in Young Adulthood
Source: ClinicalTrials.gov · Last updated 12 Jan 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to understand more about why young people who were born to a hypertensive pregnancy may have increased risk of high blood pressure and are often at increased risk of heart and blood vessel disease later in life.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 7 Nov 2022
- Start date
- 17 Nov 2022
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- University of Oxford
- Diseases
- High blood pressure
- NCT number
- NCT05683093
What you commit to
- Study type: Observational
- Planned participants: 200
- From 17 Nov 2022 to the primary completion date, 1 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Planning to donate blood within two weeks prior to study visit 1
Other illness
- Any significant disease or disorder which, in the opinion of the investigator, might influence the participant's ability to participate in the study
- Evidence of congenital heart disease or significant chronic disease relevant to cardiovascular or metabolic status
- For exclusion of MRI component only:
Other
- Pregnant or lactating when they are due to attend for study visit 1
- Less than six months postpartum
- Unsuitable for MRI based on participant screening; the participant may still be included in other parts of the study
Who the study is looking for
- Participant is willing and able to give informed consent for participation in the study
- Male or female, aged 30 to 40 years at time of enrolment
- Participant previously took part in the ALSPAC study
- Able (in the investigator's opinion) and willing to comply with all study requirements
- Adequate understanding of verbal and written English
Age in the registry: 30 years to 40 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Oxford Coordinator of this site? Confirm its status | Oxford | United Kingdom | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.